ARCHIVES

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

This article is from The Cancer Letter archive.

Vol. 05 No. 01 | January 5, 1979

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990

NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.

February 25, 2000